Tuesday, February 19, 2013

Colleen, PH Specialty Pharmacies and You...


Here is a guest blog from Colleen Brunetti ... co-founder of PHA's Generation Hope, blogger and PHA Board member.  As you'll see below, Colleen well represents the Power of One as it's exercised for the good of many. Soon, the Specialty Pharmacy Feedback Committee will come to reality. You'll be hearing a lot more details from PHA as that takes place...

Colleen BrunettiToday I am thrilled to bring to the PH community a new initiative that, for me, has been several years in the making. But first, here’s how we got to today…

I have been diagnosed with PH for five years, and like many of you, quickly had to learn to navigate a very complex healthcare system, including the delivery and management of medications that can only be procured through a specialty pharmacy.

It wasn't very long into this experience that it became apparent that this is not always a seamless process. For a couple of years I struggled to get deliveries as promised, or I would call to order a prescription only to find out I needed a renewal (which delayed delivery), or be blindsided by company protocols that did not meet my needs as a patient and made me very concerned for the specialty medication delivery process for the patient community as a whole.

As I fought these issues out one by one, and participated in online PH communities where it was abundantly clear that I was not the only one going through challenges, it became obvious to both PHA and myself that something needed to be done.

PHA has been helping me address these concerns via the Corporate Committee, a group of representatives 

from many of the major companies who have a stake in the PH experience (specialty pharmacies, drug manufacturers, etc.). It started with a letter I wrote to the committee over a year ago expressing my concerns and frustration. The letter was well received by industry representatives and we have been assured of their cooperation and support with what I am about to share.

Through our ongoing and collaborative efforts, I am very pleased to tell you that we are in the processes of forming a Specialty Pharmacy Feedback Committee. This committee will be comprised of patients, caregivers, industry representatives, PHA, and Caring Voice Coalition. Our goal is to create a process by which patients can quickly and efficiently get major concerns with their specialty pharmacy addressed. Further, we will strive to identify both areas where improvements can be made, and also best practices that can be implemented.

This feedback process will be accomplished through an online form which will soon be available on both PHA’s and Caring Voice Coalition’s websites. Our goal, however, is not to become only a complaint department. We want to help by empowering patients to reach out to the right people within their respective provider network, and to help all parties involved understand how to avoid repeat issues in the future.  We want to help specialty pharmacies see where their procedures are not meeting patient needs, and to also see what is working well.

In addition, this form can be used for praise and accolade. Many of us have had fantastic experiences with representatives from specialty pharmacy companies and they need to hear about this too. When we start from a strength-based model, and move forward on what works, we all benefit.

You will be hearing more about this process in the coming months. In the meantime, we welcome your feedback! Feel free to leave a comment on this blog on what you think of this new initiative, ideas you have on how it can best serve your needs, and anything else on this topic that you wish to comment on.

In closing, I would like to take a moment to thank PHA, Caring Voice, and especially the industry representatives who are supporting this process. It isn’t often that we get to see how a patient is not only heard, but responded to in such a positive and pro-active way. I really appreciate that our community is being given this platform, and with such support from all involved. Thank you!

Monday, February 4, 2013

From Orlando to Istanbul…

At PHA’s 2012 International PH Conference and Scientific Sessions in Orlando, Fla., one of our medical speakers during the Scientific Sessions was Dr. Ghazwan Butrous, a Professor of Cardiopulmonary Sciences at the University of Kent in the United Kingdom. His presentation on schistosomiasis, an infection (caused by parasitic worms in contaminated water) that is a primary cause of pulmonary hypertension in South America, Asia and Africa, is now available on PHA Online University and is well worth watching.


We have known Dr. Butrous since, as a scientist at Pfizer, he played a critical role in demonstrating the value of sildenafil for treatment of pulmonary hypertension. Today, he plays another important role as Managing Director of the Pulmonary Vascular Research Institute (PVRI), an organization of physicians with whom PHA has been developing an increasing number of partnerships.

Grand Bazaar
There are many connections between PHA and PVRI, and at the end of 2012 I got a call from Drs. Stuart Rich and John Newman. Dr. Rich is a past member of PHA’s Scientific Leadership Council (SLC) and co-founder of PVRI, and Dr. Newman is immediate past chair of PHA’s SLC and active in PVRI. They invited me to attend PVRI’s annual meeting in Istanbul to address the group on what patients want from medical research and to discuss a potential clinical trials initiative.

When I heard the question – what do patients want from medical research, I was really pleased. Here were Dr. Rich and Dr. Newman, researchers who played important roles in building this field, asking a question we had rarely heard before.

Hagia Sophia
I accepted and began developed a survey. Once it was ready and posted online, Kim Lamon-Loperfido, who manages PHA’s Patient Outreach and Services, circulated a single Facebook message to let our community know it was available. Twelve hours later I checked to see if anyone was interested. To my astonishment, 143 people had already completed the survey … and within 72 hours we had met our goal of 250 respondents. This was no small statement of interest since we estimated completion would take 35 to 45 minutes. 

Michael Gray and Briana Rivas-Morello in our Medical Services program volunteered to analyze the data and developed a detailed report and slide deck which I was able to present on Tuesday, Jan. 22, in Istanbul to the almost 200 physicians and researchers from around the globe who attended.
Topkapi Palace
The presentation was part of a symposium on the possible development of a global clinical trials consortium. Besides my presentation from the perspective of patient advocacy groups, Drs. Rich and Newman chaired sessions that included perspectives from academia, industry and government.
PHA’s presentation was well received, and we have already received considerable interest in more information from many who attended. Our next step will be to share the information with PHA’s Scientific Leadership Council so that one or more researchers can be encouraged to expand and refine it for publication. At that point, we look forward to sharing the information with those who participated in the survey, the rest of our PH community and researchers in other fields who are finding this topic of growing interest.

One thing that is already crystal clear from the survey is that patients want more information than they are getting from the research in which they are participating – and those who are not participating could be encouraged to do so with more information.

Dr. Al- Hazmi bringing the
Sometimes It's PH Campaign
zebra stripes to Istanbul
At PHA we will begin working on this and, as our information is reviewed and further developed, you will be hearing more about it.

I cannot write this without saying that Istanbul – with its long and historic blending of East and West – was a perfect place to host this global meeting. The meeting was hosted by the Saudi Association for Pulmonary Hypertension and at an evening event, I pointed out to Dr. Manal Al-Hazmi from Riyadh, Saudi Arabia, that her blouse looked like zebra stripes. She replied, “Of course, that’s why I chose it … to support the early diagnosis campaign and bring awareness to Istanbul!”

There is no question that we are all in this fight together.

Thursday, January 17, 2013

PH + [Your Condition Here] + People Who Understand

PH and Lupus
This week I had the chance to see a great set of four new PHA videos in which patients and doctors talk about their experience with PH and Scleroderma, PH and HIV, PH and Congenital Heart Disaease and PH and Lupus.  The videos are connected to PH Plus, a community of patients within PHA who live with PH and another related illness. Thanks so much to all who were willing to tell their stories and share their experiences and knowledge, and to Kim Lamon-Loperfido, PHA's Manager of Patient Outreach and Services for her work on this project and for writing this guest blog ... oh, and after you watch the videos, please help PHA maintain the quality of the resources we provide for you by taking the short survey on these videos.  Thank you!

PH and Scleroderma
As I started my tenure at PHA in August, I was tasked with seeing a new video series from post-production work to “live” on the PHA website. As a new staff member, I have learned so much about PH and associated conditions through watching these videos and I hope that you do too! In this video series, you will hear stories from PH patients living with associated diseases (lupus, CHD, HIV and scleroderma) and the healthcare professionals who treat them. 

Some of the key facts I learned through the video series included:

·       About 5 in 1,000 Lupus patients develop PAH. It is critically important to do further testing to determine if it is PAH causing the shortness of breath. Lupus can affect the heart, heart valves, lung and muscles that surround the lung and chest wall. 

·       1 out of every 200 HIV patients develops at least mild PH.

·       PAH is a common complication of scleroderma. Between 8 to 12 percent of all scleroderma patients develop PAH.

But beyond the medical facts, the videos feature the provocative personal stories of patients and medical professionals in a very accessible way. Here are some highlights:

PH and HIV
·       “The most challenging part of living with multiple illnesses is managing your care.” — Anna Bower

·       “Scleroderma and PH is not my identity ... If your sickness becomes your identity, then you don’t have a shot. You have to surround yourself with people that do not make you feel sick.” - Tammy Gilbert

PH and Congenital  Heart Disease
·       I think that the following quote by Richard Krasuski, MD, emphasizes the importance of this video series: “To be able to recognize [PH in association with another condition] requires an astute doctor and an astute patient.”

If patients experiencing and doctors treating scleroderma, CHD, HIV or lupus know that there may be an increased risk for PH, there may be a reduced time to diagnosis.  And, as we know from the Sometimes It’s PH campaign, when patients with PH are diagnosed early, they have improved chances for a better life.


Monday, December 31, 2012

As we begin 2013…an important new direction for PHA

Carl Hicks, Bette Perez, Lisa Beth Gansberg, Gina Parziale, Rino Aldrighetti
Almost exactly one year ago, I began an important new conversation with PHA’s Board of Trustees.

At that time, PHA was able to look back on significant and almost uninterrupted growth during the past dozen years.  Looking forward, however, we anticipated that, without changes, this growth could be at risk.
Let me start by explaining why growth is important in our disease state and the risks we face and then I will talk about our plans for the future.

PHA has always known that it is no less complex or expensive to solve the problems of a disease state like PH, with our 20,000 to 30,000 diagnosed patients in the U.S., than it is to solve the problems of a disease like diabetes (24,000,000 diagnosed in the U.S.) or arthritis (73,000,000).  In the face of that reality, we have built a system that has allowed us the funding to do what we need to do.  That system has been built upon our members and friends who give very generously, special events organized at the grass roots level, external givers like foundations and industry.
Industry giving has been significant and there is a reason for their strong support.  PH – which had no treatments before 1996 and only one (Flolan) until 2001 – has as many or more treatments today than all but two of the 7,000 rare diseases identified in the U.S. by the U.S. government.  Here is that list as of June 2011:
Leukemia…………….25
HIV/AIDS…………….24
PH/PAH………………..9
Hemophilia……….….9
Growth failure….….8


Having said that, industry giving functions parallel to their business cycle in a disease.  As their products mature and move toward generic availability, the good news is that pricing will go down…we are already seeing that with Revatio.  However, the other side of the coin is that we anticipate this segment of PHA’s funding will begin to recede. 
Even if industry funding was to hold steady or increase – and, with new products in the pipeline, that might well happen – PHA still needs to develop alternate funding.  We have always been driven to do all that needs to be done and never to be limited by the size of our patient population.  As we have grown, we have been asked to – and strive to – do more:

·       to coordinate, train and assist a support group network that will shortly include over 250 groups

·       to organize and provide essential online and face to face medical education for a medical community that is rapidly growing

·       to develop and assist patient and caregiver groups for segments of our community with specific needs and interests

·       to increase support for adult and pediatric PH research within our five research programs

·       to support the development of a system of standards that will result in defined and accredited PH Centers of Care to improve the quality of clinical treatment for patients

·       to rapidly expand our early diagnosis campaign, Sometimes It’s PH, toward our goal of reducing the time from onset of symptoms to point of diagnosis over the next five years

·       and so much more…to see, all you have to do is look at PHA’s three primary websites, www.PHassociation.org, www.PHAonlineuniv.org and www.SometimesItsPH.org. 
All this is exciting opportunity to make things better for our community…but it also requires significant resources. 

So, that’s why continuing growth is important and those are the risks we face.  Now let’s talk about how PHA is responding.
At PHA’s board meeting in early 2012, I talked to our board about the same issues I am writing about in this blog and we began a discussion to ensure our sustainability…an eight month process of search and discovery.  Our goal has been to find and build a structure that will keep PHA strong and independent in the coming years to do all the things we must do. Our timetable was to make a decision and establish our new structure for this goal by January 1, 2013.
As I post this blog on the last day of 2012, it was quite a trek but we have met that goal.
In the early months of 2012, board and staff began to investigate and discuss different options.  For various reasons, each was rejected as not being capable of fully meeting our needs.
Then, on July 17, we had a full day meeting with the leadership of the Cystic Fibrosis Foundation. 
Our history went back a long way with CFF.  A year or so after I began work with PHA as its first staff person, board member Jack Stibbs and I had a number of meetings with Bob Dresing, who was one of the founders and who had been CFF’s first CEO.  More recently, our Scientific Research Council had been working closely with Dr. Bruce Marshall, their VP of Clinical Affairs about their development of Centers of Excellence.
At our July meeting, we brought in 5 board members with business and medical background and 5 staff.  We went through a number of issues with their long-time CEO Bob Beall and COO, Rich Mattingly and a number of others. 
During follow-up discussions, it was clear that we had unanimous agreement that their Chapter structure fit both our mission and goals.
 We had a target.  In the end though, it’s always about people.  To maximize our chances of success, we now needed to staff that target…and staff it we did.
On October 1, Carl Hicks became the first member in PHA’s history to move from a board position to a staff position.  Following his resignation from the board, we hired Carl to fill a newly created position, Vice President for Field Operations…certainly not because he was a former board Chair but because – with his military and corporate leadership experience at the highest levels – Carl is clearly the right person for this job.
Our task is to create new funding streams to support the work described above and the work to come.  In the first year, the plan we developed calls for three such Chapter offices to be established and brought to significant profitability within the first 12 months.
Carl has been working rapidly since early October to build this new support element for our structure.  By November he had completed the process of city selection for our first three Chapters.  Once New York, Chicago and San Francisco had been chosen, over 100 resumes were collected and, following many phone screenings among the candidate pool, he began to travel to each of the cities.  In New York, he and Joanne Sperando Schmidt – a support group leader, event organizer and former board member – completed nine first round interviews in a day.  He did eight interviews the next day in Chicago with Liz Rossi – who had organized some of PHA’s earliest large events.  He repeated the process in the San Francisco area with participation by PHA board member Rita Orth.
By late November, Carl and I began second round interviews at the PHA office.  In early December, we had completed hiring for PHA’s first three Chapter Executive Directors:
·       New York: Gina Parziale has well over a decade of rapidly increasing responsibility among New York area non-profits, serving as the District Director of the Muscular Dystrophy Association and the Division Vice President of the American Liver Foundation (New York/New Jersey).

·       Chicago: Lisa Beth Gansberg has been developing fundraising events for over a decade and a half.  Her work has benefited organizations such as the Chicago Chapter of the Arthritis Foundation, the National Kidney Foundation of Illinois, the National Kidney Foundation of Illinois and the National ORT.

·       San Francisco: Bette Perez has been leading non-profits in the Bay area for over two decades with strong experience in special events and major giving.  These include St. Vincent DePaul Housing and United Way of Sonoma-Mendocino-Lake.  (Bette set a record after being hired, securing the first major gift through the new Chapter structure within an hour of accepting her position!)
On December 18, we began a three and a half day training for our three executive directors at PHA’s office in Silver Spring, Maryland. Besides learning about PH and PHA…
·       we analyzed their needs so that the national office is positioned to provide effective support

·       they connected with each other to form a strong team

·       they developed their budgets

·       funding goals were established

·       advertising was placed (and hiring has begun) for what will soon be three person field offices in each of the cities
We have hit our first two goals.  Our first field offices have been established with strong leadership.  Our national office is positioned to provide necessary support for the field structure’s success.  Now, in the new year, the field offices will begin to raise funds as a key component of the funding strategy that will allow PHA to continue to respond to our community’s needs.  Our third goal is to bring each of the Chapters to positive income flow by August.  Following that milestone, we will continue to expand the field structure annually
So, as we close one year and open another, I present this to you as a window to future opportunity for our community. 
As I wrote above, it is no less expensive to solve the issues of a rare disease than one with millions of patients.  We cannot be limited by our numbers.  We must always find ways to exceed them. If we do not fight for this community, if we do not work to defeat this disease, who will?
We have a plan.  We have a team,  We have a worthy and critical cause.
May 2013 be a year of new breakthroughs and realized opportunity.

Thursday, December 20, 2012

As we close 2012, a request to you…

As we close this year, I can only think back to where PHA started years ago.  How much has changed during the past decade.  How much has improved!

While there is still so much more to be done, in 2012 we truly have made great progress in our fight against pulmonary hypertension. If you haven’t already, I encourage you to read PHA’s 2012 Annual Report (PDF).

The increases in research funding, the expanded patient programming, the launch of our early diagnosis campaign none of these advances would be possible without the support, passion and drive of community members…people like you.

Our fight continues.  It will not be over until we have a cure. If you are able, I ask you to make a tax-deductible donation to PHA’s End of Year Appeal and support our fight against PH in 2013.

In these uncertain times, it’s even more important that we all pitch in. We are a small community, and the actions of each of us resonate and have a great impact on the progress of our mission. Your donation to PHA’s End of Year appeal will help PHA carry out our mission in 2013.    Each year we are called to do more…

·       in 2013, medical leadership will be launching a new program to enhance the quality of treatment for patients in our new and growing field, 

·       our new pediatric research fund – the first of its kind in the world – will be making its initial grants

·       the number of PHA support groups is on track to grow to over 250 early next year, an extraordinary number for a community our size

·       the number of state Medicaid and other insurance issues we face have been and are expected to continue to grow rapidly

·       we have been invited to partner in developing a global clinical trails initiative to help accelerate PH research

·       and, much, much more.

Your help is essential to our ability to meet the growing opportunities to make a difference for those living with PH.  And remember, Actelion Pharmaceuticals has made a generous offer to match the first $25,000 in donations from PHA supporters dollar for dollar.  Please make a tax-deductible donation now.

For information on making gifts of stock, please email Giving@PHAssociation.org.

Thank you so much.  I wish you good holidays...back to blogging in 2013!

Tuesday, December 18, 2012

Conference 2012...a view from China

Patients,family members and medical professionals from 30 nations registered for PHA's Tenth International PH Conference in Orlando in June of 2012. Recently, we received a gift from Huanghuan. She is a leader of the iSeekPH Hope Center in Beijing, China...and a very good filmmaker. Here is her view of Conference 2012. Thank you Huanghuan!
(The video begins after a short commercial.)

Saturday, December 8, 2012

Sometimes those that have lost the most give most back...

Sometimes those who have lost the most give most back...

Those were the words of the Fox 8 news anchor in Winston-Salem, N.C. as he interviewed PHA advocacy leader and Board member Diane Ramirez.

It's true. So many of those in our community take what life has put in their path and grown heroically. The segment where Diane appeared is titled Inspired Living. It usually runs 60 to 90 seconds. Diane's interview runs two and a half minutes. Beneath the video Diane is described as "a woman who didn't give up, so others may not have to either."  The PHA website appears below those words, creating greater awareness of PH.

Congratulations and thank you Diane. You are a model for us all.

View the video